AAV Control Particles for Gene Delivery and Transduction Studies

It is a packaged AAV preparation carrying a defined control genome rather than the experimental payload. The control may encode a reporter, contain a non-targeting sequence or reproduce the vector backbone without the active gene of interest.

Usually yes when the goal is to control for capsid-dependent entry, tropism and cellular response. A different serotype may be useful for screening, but it is not a fully matched negative control for the experimental vector.

A reporter particle is excellent for confirming delivery and expression, but reporter expression can itself affect cells and the cassette may differ from the test vector. For biological comparisons, a matched non-targeting or backbone control may be more appropriate.

Use a small dose range informed by the reported titer, cell type and prior data. Measure both transduction and cell health. The lowest dose that provides the required delivery is often preferable to unnecessarily high vector exposure.

Receptor availability, intracellular trafficking, promoter activity, cell state and culture conditions can all influence observed expression. A common particle preparation does not guarantee equal functional delivery across different models.

Not without qualification. Physical measurements estimate particles or vector genomes, while functional titers reflect successful delivery and expression under defined conditions. Their relationship can vary by preparation and assay.

Include untreated cells, a matched control particle and, where useful, a positive reporter control. For editing or knockdown, verify the intended molecular change independently and monitor vector-related toxicity or immune responses.

Follow the product-specific temperature and handling instructions, prepare suitable aliquots and avoid repeated freeze-thaw cycles. Compare control and experimental particles using equivalent storage histories whenever possible.